Steroplast Healthcare Limited

POWER SEARCH PRICING

SOLUTIONS

steroplast healthcare limited Company Information

Company Number

00504340

Next Accounts

Dec 2025

Directors

Adam Brown

Mohammed Ramzan

Shareholders

adam carter brown

mark doncaster brown

Group Structure

View All

Industry

Non-specialised wholesale trade

Registered Address

alpha point, bradnor road, manchester, M22 4TE

Website

www.steroplast.co.uk

steroplast healthcare limited Estimated Valuation

£4.9m

Pomanda estimates the enterprise value of STEROPLAST HEALTHCARE LIMITED at £4.9m based on Net Assets of £2.1m and 2.38x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Steroplast Healthcare Limited is a live company located in manchester, M22 4TE with a Companies House number of 00504340. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in March 1952, it's largest shareholder is adam carter brown with a 95.2% stake. Steroplast Healthcare Limited is a mature, small sized company, Pomanda has estimated its turnover at £4.5m with low growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Steroplast Healthcare Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

2 Strong

3 Regular

7 Weak

Size

annual sales of £4.5m, make it smaller than the average company (£14.4m)

Growth

3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (8.2%)

EXPORT

Steroplast Healthcare Limited's latest turnover from March 2024 is estimated at £4.5 million and the company has net assets of £2.1 million. According to their latest financial statements, Steroplast Healthcare Limited has 30 employees and maintains cash reserves of £622.4 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	4,512,982	5,346,761	5,362,162	4,494,984	5,434,263	5,447,764	5,051,281	5,419,584	5,106,561	5,603,073	5,449,438	4,871,975	4,490,350	4,184,947	4,130,621
Other Income Or Grants
Cost Of Sales	3,211,573	3,812,274	3,815,506	3,246,279	3,884,719	3,886,368	3,600,267	3,800,587	3,559,839	3,936,279	3,814,249	3,404,674	3,137,114	2,913,669	2,865,904
Gross Profit	1,301,409	1,534,488	1,546,656	1,248,705	1,549,544	1,561,397	1,451,014	1,618,997	1,546,722	1,666,794	1,635,189	1,467,301	1,353,236	1,271,278	1,264,717
Admin Expenses	1,310,325	2,615,823	1,335,570	1,118,708	1,522,120	1,373,844	1,413,513	1,559,295	1,526,851	1,464,712	1,444,411	1,425,605	990,097	952,732	-1,107,907
Operating Profit	-8,916	-1,081,335	211,086	129,997	27,424	187,553	37,501	59,702	19,871	202,082	190,778	41,696	363,139	318,546	2,372,624
Interest Payable			4,324	12,738	18,278	21,573	22,031	10,889
Interest Receivable	24,113	17,665	5,086	728	559	2,209	1,160	760	818	733	538	769	1,397	1,182	554
Pre-Tax Profit	15,197	-1,063,670	211,848	117,986	9,705	168,189	16,630	49,573	20,689	202,815	191,317	42,466	364,536	319,728	2,373,178
Tax	-3,799		-40,251	-22,417	-1,844	-31,956	-3,160	-9,914	-4,138	-42,591	-44,003	-10,192	-94,779	-89,524	-664,490
Profit After Tax	11,398	-1,063,670	171,597	95,569	7,861	136,233	13,470	39,658	16,551	160,224	147,314	32,274	269,757	230,204	1,708,688
Dividends Paid
Retained Profit	11,398	-1,063,670	171,597	95,569	7,861	136,233	13,470	39,658	16,551	160,224	147,314	32,274	269,757	230,204	1,708,688
Employee Costs	1,295,853	1,268,414	1,180,843	1,147,368	1,107,734	1,052,649	1,097,133	1,067,392	939,689	952,306	970,628	865,049	797,725	747,690	797,727
Number Of Employees	30	31	30	31	30	29	31	31	28	29	30	27	25	24	26
EBITDA*	53,151	-1,022,504	259,871	190,281	112,583	220,006	37,501	62,862	89,800	268,469	256,511	109,716	416,582	386,798	2,446,896

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	175,388	206,042	873,555	874,286	936,588	996,954	986,815	958,022	962,726	1,000,932	973,322	1,000,660	926,605	898,401	928,460
Intangible Assets
Investments & Other			402,204	401,630	401,630	400,559	396,690	388,045
Debtors (Due After 1 year)
Total Fixed Assets	175,388	206,042	1,275,759	1,275,916	1,338,218	1,397,513	1,383,505	1,346,067	962,726	1,000,932	973,322	1,000,660	926,605	898,401	928,460
Stock & work in progress	1,129,636	1,342,713	909,233	981,592	899,509	1,109,242	1,216,393	1,063,578	1,116,543	1,026,647	981,294	1,143,491	992,853	869,788	841,958
Trade Debtors	552,618	833,786	1,027,291	685,350	1,022,939	936,543	891,536	969,062	906,956	1,199,118	1,096,027	884,845	810,548	751,121	669,693
Group Debtors		2,792
Misc Debtors	36,429	24,096	67,359	139,814	199,768	131,264	115,851	163,496	210,962
Cash	622,377	296,208	535,065	821,224	634,047	483,775	105,206	358,592	249,023	77,987	215,298	74	307,681	251,191	221,411
misc current assets
total current assets	2,341,060	2,499,595	2,538,948	2,627,980	2,756,263	2,660,824	2,328,986	2,554,728	2,483,484	2,303,752	2,292,619	2,028,410	2,111,082	1,872,100	1,733,062
total assets	2,516,448	2,705,637	3,814,707	3,903,896	4,094,481	4,058,337	3,712,491	3,900,795	3,446,210	3,304,684	3,265,941	3,029,070	3,037,687	2,770,501	2,661,522
Bank overdraft							18,966
Bank loan				27,021	21,962	19,903		18,663
Trade Creditors	212,708	351,810	335,494	284,671	550,658	650,590	366,188	657,858	549,114	631,021	746,054	627,944	664,916	660,732	721,773
Group/Directors Accounts
other short term finances
hp & lease commitments	8,682	9,981	8,050	1,026	6,150	7,268
other current liabilities	166,689	214,763	318,772	516,074	361,396	206,818	265,084	161,766	210,907
total current liabilities	388,079	576,554	662,316	828,792	940,166	884,579	650,238	838,287	760,021	631,021	746,054	627,944	664,916	660,732	721,773
loans				101,089	267,577	289,849	310,475	329,779
hp & lease commitments	36,999	45,681	10,733		1,025	6,057
Accruals and Deferred Income
other liabilities										4,025	9,074	32,106	32,554	60,530	121,515
provisions	14,242	17,672	12,258	16,212	23,479	23,479	33,638	28,059	21,177	21,177	22,576	28,097	31,568	10,347	9,546
total long term liabilities	51,241	63,353	22,991	117,301	292,081	319,385	344,113	357,838	21,177	25,202	31,650	60,203	64,122	70,877	131,061
total liabilities	439,320	639,907	685,307	946,093	1,232,247	1,203,964	994,351	1,196,125	781,198	656,223	777,704	688,147	729,038	731,609	852,834
net assets	2,077,128	2,065,730	3,129,400	2,957,803	2,862,234	2,854,373	2,718,140	2,704,670	2,665,012	2,648,461	2,488,237	2,340,923	2,308,649	2,038,892	1,808,688
total shareholders funds	2,077,128	2,065,730	3,129,400	2,957,803	2,862,234	2,854,373	2,718,140	2,704,670	2,665,012	2,648,461	2,488,237	2,340,923	2,308,649	2,038,892	1,808,688

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-8,916	-1,081,335	211,086	129,997	27,424	187,553	37,501	59,702	19,871	202,082	190,778	41,696	363,139	318,546	2,372,624
Depreciation	62,067	58,831	48,785	60,284	85,159	32,453		3,160	69,929	66,387	65,733	68,020	53,443	68,252	74,272
Amortisation
Tax	-3,799		-40,251	-22,417	-1,844	-31,956	-3,160	-9,914	-4,138	-42,591	-44,003	-10,192	-94,779	-89,524	-664,490
Stock	-213,077	433,480	-72,359	82,083	-209,733	-107,151	152,815	-52,965	89,896	45,353	-162,197	150,638	123,065	27,830	841,958
Debtors	-271,627	-233,976	269,486	-397,543	154,900	60,420	-125,171	14,640	-81,200	103,091	211,182	74,297	59,427	81,428	669,693
Creditors	-139,102	16,316	50,823	-265,987	-99,932	284,402	-291,670	108,744	-81,907	-115,033	118,110	-36,972	4,184	-61,041	721,773
Accruals and Deferred Income	-48,074	-104,009	-197,302	154,678	154,578	-58,266	103,318	-49,141	210,907
Deferred Taxes & Provisions	-3,430	5,414	-3,954	-7,267		-10,159	5,579	6,882		-1,399	-5,521	-3,471	21,221	801	9,546
Cash flow from operations	343,450	-1,304,287	-127,940	364,748	220,218	450,758	-176,076	157,758	205,966	-38,998	276,112	-165,854	164,716	127,776	1,002,074
Investing Activities
capital expenditure	-31,413	608,682	-48,054	2,018	-24,793	-42,592	-28,793	1,544	-31,723	-93,997	-38,395	-142,075	-81,647	-38,193	-1,002,732
Change in Investments		-402,204	574		1,071	3,869	8,645	388,045
cash flow from investments	-31,413	1,010,886	-48,628	2,018	-25,864	-46,461	-37,438	-386,501	-31,723	-93,997	-38,395	-142,075	-81,647	-38,193	-1,002,732
Financing Activities
Bank loans			-27,021	5,059	2,059	19,903	-18,663	18,663
Group/Directors Accounts
Other Short Term Loans
Long term loans			-101,089	-166,488	-22,272	-20,626	-19,304	329,779
Hire Purchase and Lease Commitments	-9,981	36,879	17,757	-6,149	-6,150	13,325
other long term liabilities									-4,025	-5,049	-23,032	-448	-27,976	-60,985	121,515
share issue															100,000
interest	24,113	17,665	762	-12,010	-17,719	-19,364	-20,871	-10,129	818	733	538	769	1,397	1,182	554
cash flow from financing	14,132	54,544	-109,591	-179,588	-44,082	-6,762	-58,838	338,313	-3,207	-4,316	-22,494	321	-26,579	-59,803	222,069
cash and cash equivalents
cash	326,169	-238,857	-286,159	187,177	150,272	378,569	-253,386	109,569	171,036	-137,311	215,224	-307,607	56,490	29,780	221,411
overdraft						-18,966	18,966
change in cash	326,169	-238,857	-286,159	187,177	150,272	397,535	-272,352	109,569	171,036	-137,311	215,224	-307,607	56,490	29,780	221,411

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for steroplast healthcare limited. Get real-time insights into steroplast healthcare limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for steroplast healthcare limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in M22 area or any other competitors across 12 key performance metrics.

STEROPLAST HEALTHCARE LIMITED group structure

Steroplast Healthcare Limited has no subsidiary companies.

Ultimate parent company

STEROPLAST HEALTHCARE LIMITED

00504340

STEROPLAST HEALTHCARE LIMITED Shareholders

adam carter brown	95.22%
mark doncaster brown	4.78%

Steroplast Healthcare Limited currently has 2 directors. The longest serving directors include Mr Adam Brown (Jul 1997) and Mr Mohammed Ramzan (Nov 2002).

officer	country	age	start	end	role
Mr Adam Brown		62 years	Jul 1997	-	Director
Mr Mohammed Ramzan		54 years	Nov 2002	-	Director

P&L

March 2024

turnover

4.5m

-16%

operating profit

-8.9k

gross margin

28.9%

+0.48%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

2.1m

+0.01%

total assets

2.5m

-0.07%

cash

622.4k

+1.1%

net assets

Total assets minus all liabilities

Similar Companies

staycold export ltd

trend international group limited

tildenet gardenware limited

2.5

quintessence fragrances limited

victoria springs limited

2.5

company number

00504340

Type

Private limited with Share Capital

industry

46900 - Non-specialised wholesale trade

32990 - Other manufacturing n.e.c.

incorporation date

March 1952

ultimate parent company

None

previous names

steroplast ltd (March 2009)

adhesive fabrics (manchester) limited (May 1988)

address

alpha point, bradnor road, manchester, M22 4TE

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 9 charges/mortgages relating to steroplast healthcare limited. Currently there are 2 open charges and 7 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for STEROPLAST HEALTHCARE LIMITED. This can take several minutes, an email will notify you when this has completed.

steroplast healthcare limited Company Information

steroplast healthcare limited Estimated Valuation

steroplast healthcare limited Estimated Valuation

steroplast healthcare limited Estimated Valuation

Steroplast Healthcare Limited Overview

Steroplast Healthcare Limited Health Check

STEROPLAST HEALTHCARE LIMITED financials

steroplast healthcare limited Credit Report and Business Information

Steroplast Healthcare Limited Competitor Analysis

steroplast healthcare limited Ownership

steroplast healthcare limited directors

steroplast healthcare limited company details

steroplast healthcare limited Charges & Mortgages

steroplast healthcare limited Capital Raised & Share Issues BETA

steroplast healthcare limited Companies House Filings - See Documents